nimodipine has been researched along with MS (Multiple Sclerosis) in 3 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nimodipine treatment attenuated clinical EAE and spinal cord degeneration and promoted remyelination." | 5.46 | Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis. ( Ergün, S; Hell, JW; Jörg, S; Koeniger, T; Kuerten, S; Linker, RA; Schampel, A; Scholz, CJ; Volovitch, O; Wischmeyer, E; Wunsch, M, 2017) |
| "Nimodipine treatment attenuated clinical EAE and spinal cord degeneration and promoted remyelination." | 1.46 | Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis. ( Ergün, S; Hell, JW; Jörg, S; Koeniger, T; Kuerten, S; Linker, RA; Schampel, A; Scholz, CJ; Volovitch, O; Wischmeyer, E; Wunsch, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Enders, M | 1 |
| Weier, A | 1 |
| Chunder, R | 1 |
| An, Y | 1 |
| Bremm, F | 1 |
| Feigenspan, A | 1 |
| Buettner, C | 1 |
| Ekici, AB | 1 |
| Mingardo, E | 1 |
| Odermatt, B | 1 |
| Kuerten, S | 2 |
| Denaroso, GE | 1 |
| Smith, Z | 1 |
| Angeliu, CG | 1 |
| Cheli, VT | 1 |
| Wang, C | 1 |
| Paez, PM | 1 |
| Schampel, A | 1 |
| Volovitch, O | 1 |
| Koeniger, T | 1 |
| Scholz, CJ | 1 |
| Jörg, S | 1 |
| Linker, RA | 1 |
| Wischmeyer, E | 1 |
| Wunsch, M | 1 |
| Hell, JW | 1 |
| Ergün, S | 1 |
3 other studies available for nimodipine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Impact of the Voltage-Gated Calcium Channel Antagonist Nimodipine on the Development of Oligodendrocyte Precursor Cells.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Differentiation; Encephalomyelitis | 2023 |
Deletion of voltage-gated calcium channels in astrocytes decreases neuroinflammation and demyelination in a murine model of multiple sclerosis.
Topics: Animals; Astrocytes; Calcium Channels; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experi | 2023 |
Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis.
Topics: Animals; Apoptosis; Calcium Channels, L-Type; Cells, Cultured; Disease Models, Animal; Encephalomyel | 2017 |